文献速递肾癌与肾肿瘤

机器人辅助根治性肾切除术:对比研究的系统综述与Meta分析

Robot-assisted Radical Nephrectomy: A Systematic Review and Meta-analysis of Comparative Studies.
PubMed 文献 · Eur Urol · 2020-11-18

RRN对比ORN可缩短住院时间、减少并发症和出血,但费用更高;对比LRN手术效果相似但费用更高。

要点

  • RRN对比ORN:住院时间更短、总体并发症更少、估计出血量更低,但总费用更高。
  • RRN对比LRN:手术时间更长、住院时间更短、总费用更高,其余手术结局相似。
  • 所有分析异质性高,多数结局稳健性差,需长期随访的随机临床研究验证。

核心结论

  • 对于肾细胞癌行根治性肾切除术的患者,RRN对比ORN可能具有住院时间更短和并发症更少等关键优势。
  • RRN对比LRN提供相似的手术结局但总费用更高。
  • 鉴于研究间高异质性和多数结局稳健性差,结论需在分析类型局限内解读,需随机临床研究长期随访获取更明确结果。

研究设计与样本

  • 系统检索MEDLINE、EMBASE和Web of Science,纳入比较RRN与LRN或ORN的回顾性和前瞻性研究。
  • 采用加权均数差(WMD)和比值比(OR)比较连续和二分变量,使用Newcastle-Ottawa量表评估质量,并进行敏感性分析。

主要发现

  • 对比LRN,RRN与更长手术时间(WMD 37.44 min;p=0.03)、更短住院时间(WMD -0.84天;p=0.02)和更高总费用(WMD 4700美元;p<0.001)相关。
  • 对比ORN,RRN与更短住院时间(WMD -3.06天;p=0.002)、更少总体并发症(OR 0.56;p<0.001)、更低估计出血量(WMD -702 ml;p=0.01)和更高总住院费用(WMD 4520美元;p=0.004)相关。
  • 所有分析均存在高异质性。

关键数值与推荐

  • 对比LRN:手术时间WMD 37.44 min(p=0.03),住院时间WMD -0.84天(p=0.02),总费用WMD 4700美元(p<0.001)。
  • 对比ORN:住院时间WMD -3.06天(p=0.002),总体并发症OR 0.56(p<0.001),估计出血量WMD -702 ml(p=0.01),总住院费用WMD 4520美元(p=0.004)。

临床怎么用

  • 对于肾细胞癌根治性肾切除术,RRN可作为开放手术的微创替代方案,可能减少住院时间和并发症。
  • 在腹腔镜可完成的病例中,RRN未显示优于LRN的手术结局,且费用更高,需结合资源与成本效益决策。
  • 临床决策应充分考虑研究间高异质性和结局稳健性差,并与患者个体化沟通。

局限性

  • 所有分析存在高异质性。
  • 多数结局稳健性差。
  • 纳入研究为回顾性和前瞻性比较研究,非随机对照试验,需随机临床研究长期随访验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Radical nephrectomy (RN) is the gold standard treatment for large and locally advanced renal tumors. Although robot-assisted radical nephrectomy (RRN) is being increasingly adopted, it remains unclear whether it offers benefits over standard laparoscopic radical nephrectomy (LRN) or open radical nephrectomy (ORN). OBJECTIVE: To compare the outcomes of robotic surgery to those of laparoscopic and open surgery in patients undergoing RN for renal cell carcinoma (RCC). EVIDENCE ACQUISITION: A systematic search was performed across MEDLINE, EMBASE, and Web of Science for retrospective and prospective studies comparing RRN to LRN or ORN. A meta-analysis evaluated perioperative safety, effectiveness, survival, and cost-effectiveness outcomes. The weighted mean difference (WMD) and odds ratio (OR) were used to compare continuous and dichotomous variables, respectively. Quality was assessed using the Newcastle-Ottawa scale. Sensitivity analyses were performed to assess the robustness of the estimates. EVIDENCE SYNTHESIS: Twelve studies involving 64 221 patients were identified and included in the analysis. Compared to LRN, RRN was associated with statistically significant longer operative time (WMD 37.44 min; p = 0.03), shorter length of stay (WMD -0.84 days; p = 0.02) and higher total costs (WMD US$4700; p < 0.001). Compared to ORN, RRN was associated with shorter length of stay (WMD -3.06 days; p = 0.002), fewer overall complications (OR 0.56; p < 0.001), lower estimated blood loss (WMD -702 ml; p = 0.01), and higher total hospital costs (WMD US$4520; p = 0.004). There was high heterogeneity across all analyses. CONCLUSIONS: In patients undergoing RN for RCC, RRN seems to offer some key advantages compared to ORN, including shorter hospitalization and fewer complications. Compared to LRN, RRN provides similar surgical outcomes but at higher total costs. These findings should be interpreted within the limitations of this type of analysis, given high heterogeneity between studies and poor robustness for most outcomes. Randomized clinical studies with long-term follow-up are needed to obtain more definitive results. PATIENT SUMMARY: In patients with renal cell carcinoma, robot-assisted radical nephrectomy shows perioperative advantages compared to open radical nephrectomy, but not compared to laparoscopic radical nephrectomy.

来源:Eur Urol,查看原文。版权归原作者所有。

引用

  1. Crocerossa F, Carbonara U, Cantiello F, et al. Robot-assisted Radical Nephrectomy: A Systematic Review and Meta-analysis of Comparative Studies. Eur Urol. 2020. PMID: 33218826. doi:10.1016/j.eururo.2020.10.034

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。